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Abstract
To retrospectively evaluate databases for indications and results of “bench surgery technique” in ex vivo or ex situ renal cancer resection as a lost 
alternative of savage renal function in renal malignancy or benign large tumors. We retrospectively evaluated PUBMED databases, including 
studies from 1980 to 2020. Only very few studies had analyzed “ex vivo [and] ex situ renal resection, extracorporeal renal resection, [and] renal 
autotransplantation.” Ex vivo renal resection and autotransplantation is the last chance in patients with renal cancer, but manifests numerous 
difficulties during and after the surgery. However, we noted that in some patients it provided good control over cancer, prevented long-term 
 dialysis, and avoided renal transplantation, thus giving patients a good quality of life.
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Introduction
Renal cancer requires a combination of demolitive surgery 
and therapy. However, some renal tumors are considered 
unresectable or not nephron-sparing because of large size or 
for involvement of the inferior vena cava (IHV) or because 
kidney cannot safely tolerate total vascular occlusion over 
about 90 min. Ex vivo renal resection and autotransplanta-
tion (EVRRAT) means removal of the kidney from abdom-
inal cavity, the subsequent resection of the tumor lesion 
on the table in cold ischemia (bench surgery) and the sub-
sequent reimplantation of the same organ deprived of the 
tumor with nephro-sparing technique (NST). The first renal 
autotransplant was performed in 1963 by Hardy et al. (1) 
in Jackson, MS, for a high ureteral injury during an aortic 
operation. Indications for EVRRAT are as follows: multi-
ple bilateral tumors, tumors in patients with impaired renal 
function, tumors of the solitary kidney, and large benign 
tumors. In these cases, it is mandatory to preserve as many 
nephrons as possible (2–8).
Methods
We retrospectively evaluated PUBMED databases, including 
the studies from 1980 to 2020. Only a very few studies have 
analyzed “ex vivo [and] ex situ renal resection,  extracorporeal 
renal resection, [and] renal autotransplantation.” Two 
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independent research conducted the review. The search 
terms were identified with medical subject heading (MeSH). 
Research inclusion criteria were the following terms: “ex 
vivo, ex situ renal resection, extracorporeal renal resec-
tion, [and] renal autotransplantation.” The outcomes were: 
indications, operative time, morbidity and mortality, and 
oncologic results. We excluded abstracts of all manuscripts 
as well as non-English manuscripts. After rejecting review 
 articles and repetitive reports, the relevant literature included 
14 manuscripts.
Results
In 1993, Hitchcock et al. (9) reported EVRRAT in a 12-year-
old patient with spinal Ewing sarcoma underwent renal 
sparing autotransplantation to avoid radiation nephri-
tis by positioning the kidney outside the field of radiation 
to prevent radiation damage. Abraham et al. (10), in their 
retrospective study of three patients, showed an operative 
time of 5–8 h and a cold ischemia of 90–150 min through 
laparoscopic approach. The authors confirmed that it was 
a good procedure if  possible to apply. Gill et al. (11) and 
Meng and colleagues (12) reported on retroperitoneal lapa-
roscopic nephrectomy and autotransplantation in four and 
two patients, respectively. Aslam et al. (22) had reported 
three case series of laparoscopic EVRRAT with one deep 
vein thrombosis and renal infarction of transplanted kidney. 
El Tayar et al. (13) and Maughan et al. (14) treated a large 
aneurysm by nephrectomy, ex vivo repair, and autotrans-
plantation. Pretorian et al. (15) saved a patient from renal 
insufficiency due to renal reflux by performing a two-stage 
renal autotransplantation. Chandak et al. (16) applied EVR-
RAT for mycotic aneurysm. Bourgi et al. (17) treated nine 
patients for various pathologies, demonstrating a good post- 
operative creatinine clearance. While Pettersson et al.  (18) 
showed the good oncologic result after 32 months of EVR-
RAT for urothelial carcinoma of the upper urinary tract, 
demonstrating only one radical nephrectomy for cancer 
recurrence in eight patients. Holmang and Johansson (19) 
conducted autotransplantation in 23 patients with urothe-
lial neoplasm of the upper urinary tract, and concluded 
that renal autotransplantation could be harmful compared 
with standard nephroureterectomy. Komiakov et al. (20) in 
a 4-year  follow-up of EVRRAT for renal tumors in nine 
patients established no dissemination of tumor and func-
tional condition of the transplanted kidney. In 2015, Tran 
et al. (21), in their study of 52 patients, referred to more than 
90% success rate over a 6-year follow-up period.
Discussion
EVRRAT achieves nephron-sparing in renal 
tumors.  Kidney autotransplantation is performed to 
preserve renal  parenchyma. If correct indications are fol-
lowed,  EVRRAT presents a viable and last option before 
nephrectomy whereas traditional surgery exposes the patient 
to chronic renal insufficiency (CRI) (17). Open surgery in 
EVRRAT is the best choice, but laparoscopic approach could 
be used to reduce morbidity of the procedure. Laparoscopic 
technique allows minimal skin incision. Renal extraction and 
subsequent transplantation could be performed through a 
standard extraperitoneal Gibson incision, with minimiza-
tion of postoperative pain and length of hospital stay (11). 
Renal autotransplantation is an option for a highly selected 
group of patients having multiple bilateral tumors, tumors 
in patients with impaired renal function, and tumors of the 
solitary  kidney; complex renal artery aneurysms; and high 
ureteric injuries, which are the most common indications of 
EVRRAT (17). It has short- and long-term complication rates 
comparable with those of other major surgical procedures.
Conclusions
EVRRAT is the last chance in patients with renal cancer. 
However, it has manifested numerous difficulties during 
and after surgery, with a local recurrence rate of 25% and 
a vascular thrombosis of 20%. However, as encountered in 
literature reviews, we noted that in some patients it provided 
good control over cancer, prevented long-term dialysis, and 
avoided renal transplantation, thereby giving the patients a 
good quality of life (2–8,22,23).
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